Q1 2024 OrthoPediatrics Corp Earnings Call Transcript
Good morning and welcome to OrthoPediatrics Corporation's First Quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to Tripp Taylor from Gilmartin Group for a few introductory comments.
Thank you for joining today's call. With me from the Company are David Daly, President and Chief Executive Officer, and Fred Hyde, Chief Operating and Financial Officer.
Before we begin today, let me remind you that the company's remarks include forward-looking statements within the meaning of federal securities laws, including the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to numerous risks and uncertainties, and the Company's actual results may differ materially. For a discussion of risk factors. I encourage you to review the company's most recent annual report on Form 10-K, which was filed with the SEC on March eighth,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |